PEGORARO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.454
AS - Asia 20.869
EU - Europa 11.655
AF - Africa 3.869
SA - Sud America 3.619
Continente sconosciuto - Info sul continente non disponibili 800
OC - Oceania 379
Totale 82.645
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.855
SG - Singapore 6.219
CN - Cina 3.439
IT - Italia 3.026
VN - Vietnam 2.552
HK - Hong Kong 2.234
BR - Brasile 2.086
BD - Bangladesh 1.146
FR - Francia 926
FI - Finlandia 869
DE - Germania 787
IN - India 674
SE - Svezia 667
GB - Regno Unito 580
CA - Canada 517
PL - Polonia 491
UA - Ucraina 449
RU - Federazione Russa 401
NL - Olanda 354
IQ - Iraq 351
TR - Turchia 350
AR - Argentina 329
JP - Giappone 273
PK - Pakistan 229
PH - Filippine 227
SA - Arabia Saudita 227
IE - Irlanda 223
ID - Indonesia 220
ZA - Sudafrica 214
CO - Colombia 211
AT - Austria 201
ES - Italia 195
MX - Messico 194
EC - Ecuador 173
UZ - Uzbekistan 157
JM - Giamaica 155
MY - Malesia 155
VE - Venezuela 150
CR - Costa Rica 149
MA - Marocco 149
KR - Corea 144
BJ - Benin 143
GT - Guatemala 143
CH - Svizzera 135
JO - Giordania 133
EG - Egitto 132
HN - Honduras 132
NP - Nepal 132
PY - Paraguay 131
CL - Cile 126
KE - Kenya 124
BE - Belgio 123
PE - Perù 122
DZ - Algeria 119
AO - Angola 118
LB - Libano 118
PA - Panama 118
TH - Thailandia 118
GR - Grecia 117
TN - Tunisia 116
ET - Etiopia 115
NI - Nicaragua 114
PS - Palestinian Territory 113
TT - Trinidad e Tobago 113
RS - Serbia 112
KZ - Kazakistan 110
AE - Emirati Arabi Uniti 109
AL - Albania 108
SI - Slovenia 108
NO - Norvegia 107
CZ - Repubblica Ceca 106
BA - Bosnia-Erzegovina 105
DK - Danimarca 105
DO - Repubblica Dominicana 105
LV - Lettonia 104
AZ - Azerbaigian 103
BO - Bolivia 103
CI - Costa d'Avorio 102
IL - Israele 102
TW - Taiwan 102
RO - Romania 101
CY - Cipro 100
ME - Montenegro 100
ML - Mali 100
PR - Porto Rico 100
BW - Botswana 99
EE - Estonia 99
HU - Ungheria 98
KG - Kirghizistan 98
PT - Portogallo 97
UY - Uruguay 97
BB - Barbados 96
BY - Bielorussia 96
CW - ???statistics.table.value.countryCode.CW??? 96
LY - Libia 96
LC - Santa Lucia 95
GA - Gabon 94
LA - Repubblica Popolare Democratica del Laos 94
UG - Uganda 94
YT - Mayotte 94
Totale 77.438
Salva come PNG Salva come JPEG
Città #
Ashburn 4.809
San Jose 3.814
Fairfield 3.669
Singapore 3.642
Woodbridge 2.323
Houston 2.060
Hong Kong 2.034
Ann Arbor 1.664
Chandler 1.403
Seattle 1.346
Wilmington 1.268
Jacksonville 1.263
Cambridge 1.231
Council Bluffs 1.051
Ho Chi Minh City 717
Boardman 698
Santa Clara 688
Los Angeles 656
Hanoi 580
Beijing 555
Princeton 543
San Diego 494
New York 444
Lauterbourg 426
Helsinki 371
Milan 350
Medford 338
Bytom 327
Roxbury 326
Padova 251
Chicago 240
Des Moines 238
Dong Ket 234
Rome 208
Nanjing 202
Buffalo 201
São Paulo 201
The Dalles 198
Dublin 182
Tokyo 174
Dallas 167
Guangzhou 160
Munich 155
Baghdad 149
Orem 142
Cotonou 137
Nuremberg 135
Tashkent 135
Da Nang 128
Amman 125
Phoenix 120
San José 115
London 113
Montreal 111
Nairobi 110
Managua 108
Panama City 108
Vienna 104
Brooklyn 103
Hefei 103
Johannesburg 99
Kingston 99
Luanda 99
Atlanta 95
Haiphong 95
Abidjan 94
Baku 94
Toronto 94
Bamako 93
Bridgetown 92
Castries 92
Libreville 92
Guatemala City 90
Kampala 90
Riga 90
Lusaka 89
Bishkek 88
Addis Ababa 86
Dushanbe 86
Jeddah 86
Podgorica 86
Istanbul 85
Vientiane 85
Naples 83
Warsaw 82
Dakar 81
Frankfurt am Main 81
Havana 81
Shenyang 81
Tianjin 81
Ulan Bator 81
Rio de Janeiro 80
Montevideo 79
Willemstad 79
Accra 78
Noumea 78
Chennai 77
Phnom Penh 77
Lima 76
Nouakchott 76
Totale 47.397
Salva come PNG Salva come JPEG
Nome #
Neuropsychological and endocrinological study in myotonic dystrophy type 1 540
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 426
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 417
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 373
Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance 358
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 349
Ablation of collagen VI leads to the release of platelets with altered function 328
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 325
Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts 323
Unimpaired Neuropsychological Performance and Enhanced Memory Recall in Patients with Sbma: A Large Sample Comparative Study. 322
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 321
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 320
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 304
Evaluation of peripherin in biofluids of patients with motor neuron diseases 304
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 302
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 298
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 297
Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle 294
Abnormal cochlear potentials in Friedreich's ataxia point to disordered synchrony of auditory nerve fiber activity 288
Collagen VI is required for the structural and functional integrity of the neuromuscular junction 287
Inositol trisphosphate receptor-mediated Ca 2+ signalling stimulates mitochondrial function and gene expression in core myopathy patients 284
A novel SACS mutation results in non-ataxic spastic paraplegia and peripheral neuropathy. 282
Natural history of Becker muscular dystrophy: DMD gene mutations predict clinical severity 280
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 278
Parkinson-like features in ALS with predominant upper motor neuron involvement 276
Muscle MRI and functional outcome measures in Becker muscular dystrophy 276
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 275
Health-related quality of life and functional changes in DMD:A 12-month longitudinal cohort study 275
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 274
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 274
New FIG4 gene mutations causing aggressive ALS 274
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies 272
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 272
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. 268
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 265
Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trials 264
POMT1 and POMT2 mutations in CMD patients: A multicentric Italian study 261
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. 260
LGMD2E patients risk developing dilated cardiomyopathy 257
Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations 255
Cardiac involvement in Becker muscular dystrophy 254
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up 253
Blood biomarkers for Alzheimer’s disease with the Lumipulse automated platform: Age-effect and clinical value interpretation 252
Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations 249
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 247
Specific numerical processing impairment in ALS patients 246
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 245
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 244
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 244
Utilità della diagnostica non invasiva ed invasiva nella stratificazione del rischio aritmico ipo ed ipercinetico nella Distrofia Miotonica tipo I. 243
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes 243
Insights into the genetic epidemiology of SBMA: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. 243
Quality of life assessment in adult spinal muscular atrophy patients treated with nusinersen 243
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes 242
The clinical spectrum of CASQ1-related myopathy 242
Redefining phenotypes associated with mitochondrial DNA single deletion 241
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy 240
Robotic Thymectomy for Myasthenia Gravis: Analysis of the Surgical and Neurological Outcomes After a 20 Years' Experience 240
Progress in enzyme replacement therapy in glycogen storage disease type II 239
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 239
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 238
1st International Workshop on Clinical trial readiness for sarcoglycanopathies 15-16 November 2016, Evry, France 238
Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction 236
MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. 235
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 234
Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis 233
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy. 233
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 232
MRI in sarcoglycanopathies: a large international cohort study 231
De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle☆ 231
Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis 229
The role of ultrastructural examination in storage diseases 228
Prognostic factors in mild dystrophinopathies. 228
Large genotype–phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis 228
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray 227
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 226
A pilot trial with clenbuterol in amyotrophic lateral sclerosis 226
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 226
The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy 225
Peculiar association of a vacuolar myopathy with multiple sclerosis. 225
X-inactivation patterns in female Leber's hereditary optic neuropathy patients do not support a strong X-linked determinant. 225
A mobile app for patients with Pompe disease and its possible clinical applications 225
Nerve ultrasound in CANVAS‐spectrum disease: Reduced nerve size distinguishes genetically confirmed CANVAS from other axonal polyneuropathies 224
Congenital muscular dystrophies with defective glycosylation of dystroglycan: apopulation study 224
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 223
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 223
A 5-year clinical follow-up study from the Italian National Registry for FSHD 221
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. 220
The role of AR polyQ tract in male breast carcinoma: lesson from an SBMA case 220
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 220
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale 220
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 220
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 216
Vaccination recommendations for patients with neuromuscular disease 216
A checklist for clinical trials in rare disease: Obstacles and anticipatory actions-lessons learned from the FOR-DMD trial 216
RFC1 expansions are a common cause of idiopathic sensory neuropathy 216
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 215
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: Experience of the FSHD Italian National Registry 215
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 215
Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes 215
Totale 26.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.153
article - articoli 195.206
book - libri 303
conference - conferenze 0
curatela - curatele 0
other - altro 1.351
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.013
Totale 432.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.888 0 0 0 430 173 378 337 506 192 177 586 1.109
2022/20233.325 804 227 55 367 555 451 16 237 385 40 147 41
2023/20241.916 73 236 214 138 136 171 104 77 105 121 253 288
2024/20258.834 49 481 456 314 1.133 236 476 732 819 401 1.471 2.266
2025/202639.694 1.350 3.042 5.927 6.597 3.131 1.644 4.481 3.383 4.219 2.457 2.013 1.450
2026/20277.468 1.846 1.830 1.990 1.802 0 0 0 0 0 0 0 0
Totale 82.645